Skip to main content

Month: June 2025

Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility

REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders under the Company’s existing senior secured term loan facility, including GoldenTree Asset Management (collectively, the “Lenders”), have agreed to reduce the rate of interest on its existing senior secured term loan facility (the “Facility”). The agreement will lower Alvotech’s interest payments in the first 12 months by an estimated US$8.2 million. This is an outcome of Alvotech’s sustained operational improvements and strengthened financial performance over the past year. “Since last year, we have shown significant revenue growth, operating profits and positive adjusted EBITDA, and...

Continue reading

Chief People Officer, Lorna Gibb to leave Nokia

Nokia CorporationStock Exchange Release26 June 2025 at 10:00 EEST Chief People Officer, Lorna Gibb to leave Nokia Espoo, Finland – Nokia today announces that its Chief People Officer, Lorna Gibb, has decided to leave the company and step down from its Group Leadership Team to pursue another opportunity, effective today. A recruitment process has begun for her successor. Lorna joined Nokia in 2020 and has been the Chief People Officer and a member of the Group Leadership Team since June 2024. She has been responsible for evolving Nokia’s people strategy and driving forward our talent and leadership programs. Esa Niinimäki, Chief Legal Officer, will assume Lorna’s responsibilities in the interim period as the search commences. About NokiaAt Nokia, we create technology that helps the world act together. As a B2B technology innovation leader,...

Continue reading

Kalmar launches Inspector – a new digital application to streamline daily equipment inspections

NB_Kalmar ServicesKalmar launches Inspector – a new digital application to streamline daily equipment inspections.KALMAR CORPORATION, TRADE PRESS RELEASE, 26 JUNE 2025 AT 10:00 AM (EEST) Kalmar launches Inspector – a new digital application to streamline daily equipment inspections Kalmar has announced the launch of Inspector, a digital inspection application to streamline routine inspections of material-handling equipment. Inspector, part of the MyKalmar ecosystem, makes equipment inspections more efficient and allows inspection data to be stored centrally for analysis and reporting purposes. The application is available as both a standalone mobile app and as an optional module for customers with a valid MyKalmar INSIGHT subscription. Timely, regular inspections of material handling equipment are critical to ensuring safety,...

Continue reading

First market launch of the adrenaline nasal spray, EURneffy®, for treatment of adults and children in Germany

ALK (ALKB:DC / OMX: ALK B) today announced the first market launch of EURneffy® 2 mg (the trade name for neffy® in the EU) in Germany. The launch of this first ever adrenaline nasal spray for timely emergency treatment of anaphylaxis represents a significant milestone for adults and children (≥30 kg) experiencing potentially life-threatening allergic reactions. With an intuitive, needle-free design, EURneffy® can help more people confidently use adrenaline when it matters most, supporting fast, reliable emergency treatment and ultimately helping improve the chances of successful outcomes and save lives. EURneffy® offers a longer shelf life (30 months) and superior temperature stability compared to existing adrenaline auto-injectors (AAIs). ALK’s Senior Vice President of Commercial Operations in Europe, Flora Beiche-Scholz, said:...

Continue reading

Tryg A/S – Q2 2025 pre-silent newsletter

Tryg will conduct pre-close analyst calls and meetings starting on 26 June, ahead of the Q2 2025 results, which will be released on 11 July. This newsletter aims to inform capital market participants of the key factors influencing the company’s recent financial performance. Insurance revenue growth Tryg maintains a balanced distribution of insurance revenue across the Scandinavian countries, with approximately 50% of revenue generated in Denmark, 30% in Sweden, and 20% in Norway. In Q2 2024, Tryg reported insurance revenue of DKK 9,545m. The commercial segment will experience a smaller spillover effect into 2025 of the derisking of the corporate portfolio carried out in 2024. In general, the group revenue development remains in line with recent development. Tryg reported a growth measured in local currencies of 3.7% in Q1 2025. When...

Continue reading

DEMIRE increases ESG performance: Company’s own CO₂ emissions reduced by 40 percent, smart meter initiative expanded

DEMIRE increases ESG performance: Company’s own CO₂ emissions reduced by 40 percent, smart meter initiative expanded Langen, 26 June 2025.  DEMIRE Deutsche Mittelstand Real Estate AG (“DEMIRE”; ISIN: DE000A0XFSF0) made decisive progress in climate protection and sustainable corporate governance in 2024: CO₂ emissions were reduced by 40 percent, ESG data collection was extended to over three quarters of the portfolio and the first green leases were implemented. Strategic development is also part of the sustainability report published today, which comprehensively documents current progress. “We are investing in transparency and controllability – both are crucial to achieving our decarbonization goals strategically and economically,” explains Frank Nickel, CEO of DEMIRE. “In doing so, we combine operational action with strategic...

Continue reading

TGS Webcast Details for Q2 2025 Presentation

Oslo, Norway (26 June 2025) – TGS, a leading global provider of energy data and intelligence will release its Q2 2025 results at approximately 07:00 a.m. CEST on 17 July 2025. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 a.m. CEST. The presentation is webcasted live. Access and registration for webcast attendees are available by copying and pasting the link below into your browser, or use the link on the front page of www.tgs.com: https://channel.royalcast.com/landingpage/hegnarmedia/20250717_2/ The Q2 2025 earnings release and presentation will be available on www.newsweb.no and www.tgs.com. For more information, visit TGS.com (http://www.tgs.com) or contact:  Bård Stenberg, VP IR & Communication Mobile: +47 992 45 235 E-mail: investor@tgs.com   About TGS TGS provides advanced data and...

Continue reading

Wereldhave strengthens credit profile with inaugural EUPP and new USPP transactions, with combined proceeds of € 125 million

Wereldhave N.V. (‘Wereldhave’) has signed its inaugural European Private Placement (EUPP) transaction, with Aegon Asset Management, securing a € 50 million loan with a tenor of ten years. The transaction, which settles on 27 June 2025, was agreed on competitive terms and follows multiple successful US Private Placement (USPP) transactions since 2011. In addition, Wereldhave agreed a new USPP transaction of € 75 million, with a tenor of seven years, with an existing USPP investor to – among others – refinance its maturing notes in the second half of 2025. Both transactions are unsecured and illustrate strong investor confidence in Wereldhave’s solid operations and strong credit profile, as recently reaffirmed by the BBB stable credit rating from Fitch Ratings in May 2025. With these transactions, Wereldhave extends the...

Continue reading

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus

Saint-Herblain, France, June 26, 2025 – Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companies, for the marketing and distribution of Valneva’s three proprietary vaccines in Germany. Under the agreed terms, CSL Seqirus will start commercializing Valneva’s single-dose chikungunya vaccine IXCHIQ® from July 2025, and Valneva’s Japanese Encephalitis vaccine IXIARO® and cholera/ETEC1 vaccine DUKORAL® from January 2026. This new agreement with CSL Seqirus replaces the marketing and distribution agreement Valneva signed with Bavarian Nordic in 20212, which is due to conclude at the end of December 2025. The new agreement will last for three years and include minimum annual purchasing quantities and standard...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.